First Manhattan’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $315K | Sell |
3,800
-10
| -0.3% | -$829 | ﹤0.01% | 609 |
|
|
2025
Q1 | $309K | Hold |
3,810
| – | – | ﹤0.01% | 581 |
|
|
2024
Q4 | $343K | Buy |
3,810
+10
| +0.3% | +$901 | ﹤0.01% | 578 |
|
|
2024
Q3 | $375K | Hold |
3,800
| – | – | ﹤0.01% | 544 |
|
|
2024
Q2 | $352K | Hold |
3,800
| – | – | ﹤0.01% | 542 |
|
|
2024
Q1 | $361K | Buy |
3,800
+300
| +9% | +$28.5K | ﹤0.01% | 559 |
|
|
2023
Q4 | $313K | Hold |
3,500
| – | – | ﹤0.01% | 566 |
|
|
2023
Q3 | $256K | Sell |
3,500
-600
| -15% | -$43.8K | ﹤0.01% | 617 |
|
|
2023
Q2 | $341K | Hold |
4,100
| – | – | ﹤0.01% | 562 |
|
|
2023
Q1 | $312K | Sell |
4,100
-3,100
| -43% | -$236K | ﹤0.01% | 594 |
|
|
2022
Q4 | $598K | Hold |
7,200
| – | – | ﹤0.01% | 488 |
|
|
2022
Q3 | $571K | Hold |
7,200
| – | – | ﹤0.01% | 490 |
|
|
2022
Q2 | $534K | Buy |
7,200
+7,000
| +3,500% | +$519K | ﹤0.01% | 526 |
|
|
2022
Q1 | $17K | Hold |
200
| – | – | ﹤0.01% | 1198 |
|
|
2021
Q4 | $22K | Hold |
200
| – | – | ﹤0.01% | 1152 |
|
|
2021
Q3 | $25K | Hold |
200
| – | – | ﹤0.01% | 1132 |
|
|
2021
Q2 | $27K | Buy |
+200
| New | +$27K | ﹤0.01% | 1113 |
|
|
2021
Q1 | – | Sell |
-100
| Closed | -$14K | – | 1577 |
|
|
2020
Q4 | $14K | Hold |
100
| – | – | ﹤0.01% | 1110 |
|
|
2020
Q3 | $11K | Buy |
+100
| New | +$11K | ﹤0.01% | 1123 |
|
|
2018
Q2 | – | Sell |
-74
| Closed | -$6K | – | 1436 |
|
|
2018
Q1 | $6K | Hold |
74
| – | – | ﹤0.01% | 1249 |
|
|
2017
Q4 | $6K | Hold |
74
| – | – | ﹤0.01% | 1297 |
|
|
2017
Q3 | $6K | Buy |
+74
| New | +$6K | ﹤0.01% | 1277 |
|
|
2015
Q4 | – | Sell |
-852
| Closed | -$53K | – | 1491 |
|
|
2015
Q3 | $53K | Hold |
852
| – | – | ﹤0.01% | 925 |
|
|
2015
Q2 | $71K | Hold |
852
| – | – | ﹤0.01% | 894 |
|
|
2015
Q1 | $64K | Buy |
+852
| New | +$64K | ﹤0.01% | 923 |
|